Biogen/Samsung Bioepis

Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B


The future of pharmacovigilance: Assessing the role of ML, NLP and other technologies

Laboratory image

Data breaches targeting pharma companies are ‘rampant,’ report says

What’s really happening with clinical trial innovation?


Kyverna Therapeutics wins $85 million in Series B financing

Leyden Labs

Leyden Labs closes $140M in Series B funding


Pfizer and BioNTech test omicron-specific COVID-19 vaccine in adults

Verana Health

Verana Health aims to go deep with its real-world data network

Gilead logo

FDA extends approval of remdesivir to encompass non-hospitalized high-risk